Research workbench
PVHL:ELOB:ELOC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4- methylthiazol-5-YL)BENZYL)CARBAMOTHIOYL) pyrrolidin-1-yl)-1- thioxopropan-2-YL)ACETAMIDE (ligand 4)
Analyse PVHL:ELOB:ELOC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6FMK
- Type
- protein
- Length
- 1,338 residues
- Chains
- 12
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Elongin-B; Elongin-C; Von hippel-lindau disease tumor suppressor
- UniProt
- Q15370, Q15369, P40337
- Ligands
- DV8
- Pockets
- 12 · best druggability 0.62
Structure
x-ray diffraction · 8 distinct chains · 33% helix, 25% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Elongin-B | protein | 104 | 17% helix, 37% strand | Q15370 |
| B | Elongin-C | protein | 87 | 48% helix, 15% strand | Q15369 |
| C | Von hippel-lindau disease tumor suppressor | protein | 141 | 26% helix, 30% strand | P40337 |
| D, G, J | Elongin-B | protein | 103 | 15% helix, 35% strand | Q15370 |
| E | Elongin-C | protein | 91 | 46% helix, 14% strand | Q15369 |
| F, I, L | Von hippel-lindau disease tumor suppressor | protein | 143 | 27% helix, 29% strand | P40337 |
| H | Elongin-C | protein | 89 | 46% helix, 15% strand | Q15369 |
| K | Elongin-C | protein | 88 | 48% helix, 15% strand | Q15369 |
Ligands and binding sites
- DV8 · ~{N}-[(2~{S})-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamothioyl]-4-oxidanyl-pyrrolidin-1-yl]-1-sulfanylidene-propan-2-yl]ethanamide · ligand · 4 copies · chains C, L, F, I
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
12 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 240 | 0.62 | 0.80 | 32 | DV8 |
| 2 | 104 | 0.59 | 0.86 | 22 | empty |
| 3 | 175 | 0.49 | 0.77 | 22 | DV8 |
| 4 | 157 | 0.43 | 0.74 | 24 | empty |
| 5 | 63 | 0.42 | 0.81 | 18 | empty |
Interfaces
18 interfaces between chains.
- G–H · 1159 Ų buried · 11 hydrogen bonds · protein-protein
- J–K · 1144 Ų buried · 13 hydrogen bonds · protein-protein
- A–B · 1141 Ų buried · 12 hydrogen bonds · protein-protein
- D–E · 1137 Ų buried · 11 hydrogen bonds · protein-protein
- H–I · 1082 Ų buried · 11 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 12 modified (artifact).
Compared structures
- 6FMK · pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)ben… · the same entry in another collection · chain K against K, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P40337
- Elsewhere: RCSB PDB 6FMK · PDBe 6FMK · UniProt Q15370 · UniProt Q15369 · UniProt P40337
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.